ctDNA_DK (@CtdnaDK) header
ctDNA_DK (@CtdnaDK) profile picture

Dansk nationalt center for behandling vejledt af kræft-DNA i blodet. Centeret er en del af DCCC og støttet af Kræftens Bekæmpelse.

Joined February 2020
Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)Photo by ctDNA_DK (@CtdnaDK)
Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by @JBjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples. Key findings: •CtDNA-negative patients: 98% RFS at 1 year •~50% are ctDNA-positive •CtDNA-positive patients: 75% RFS at 1 year •55% of Atezolizumab-treated patients cleared ctDNA & have no evidence of disease Conclusion: ctDNA shows promise for treatment de-escalation (ctDNA-) and patient selection for adjuvant therapy (ctDNA+) @Karin_Dem @IverNordentoft @SiaLindskrog @TrineStrandgaa1 @cancer_dk @DCCCcancer @CtdnaDK @AUHdk @AarhusUni
12
40
2
98
7,185
ctDNA_DK retweeted
Så er der snart frist, hvis du vil have del i DCCC’s pulje! Send din ansøgning senest d. 22. april kl. 08 – læs mere: dccc.dk/sog-stotte/ #samarbejdeomkræft #dkforsk
3
4
347
In these days @CNAPS2024 is taking place in Graz, Austria. The center is represented with both participants and presentations about circulating tumor DNA 🩸🧬 Thank you for organizing this exciting conference, #CNAPS2024 #ctDNA #CancerResearch
Great talk by Nadia Øgaard @GaardNadia on lower shedding of tumor DNA by Asymptomatic than symptomatic CRC tumors @CNAPS2024 in Graz Austria
1
6
372
Gratis AUH-foredrag - også online - om strålebehandling og kræft-DNA i blodet ved @KSeiersen fra @DCPTprotons og @ClausLindbjerg fra @moma_dk den 27. februar kl 16 fagperson.auh.dk/om-os/oplev… @CtdnaDK
3
8
433
We wish you all a Merry Christmas and Happy New Year! 🎄 Thank you for the amazing collaboration! We look forward to more national research in ctDNA guided cancer treatment in 2024 #ctDNA #CancerResearch @ClausLindbjerg | @LDyrskjot @DCCCcancer | @cancer_dk
1
4
200
BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt. Blodprøver kan være et redskab til prioritering af operationskapacitet på kræftområdet. linkedin.com/posts/aarhus-un… 📷Jens Løgstrup
3
12
405
ctDNA_DK retweeted
1000 tak @ClausLindberg fra @moma_dk for endnu engang at stille op lære fra dig af din store viden om #ctDNA 🙏🏼 det var en fantastisk god og meget pædagogisk gennemgang - spot-on til #ungekræftlæger til vores jule-webinar her til aften 🎄
2
6
325
New paper out in @Annals_Oncology 🧬📢 Great work by @TennaVesterman and the research team of @ClausLindbjerg 🙌 👉 Read the article here: annalsofoncology.org/article… #ctDNA #CancerResearch
📢 Our newest study on >800 CRC patients is now out 🧬 Read how: 1) Serial ctDNA = powerful recurrence predictor ⏳ 2) Rapid ctDNA growth = detrimental to survival 📈 3) Personalized digital PCR = clinically practical for MRD analysis💡 🔗 Read more in @AnnalsofOncology! 📰
2
6
365
Thank you for two inspiring days at the Annual Meeting 2023 last week! Focus at the meeting: 👉Updates on ctDNA research DK 👉The way from trial to clinical implementation of ctDNA 👉ctDNA RECIST as a tool for monitoring therapy response 👉Collaboration and networking across DK
1
8
372
Yesterday @ClausLindbjerg and Kåre Gotschalck visited Go'morgen Danmark on TV2 to tell about the promising research in ctDNA🧬 Funding from #KnækCancer has enabled the establishment of the national ctDNA Center and the research🙌 Find the piece at TV2 play #ctDNA #gotv2dk
1
16
517
Welcome Jakob Skou Pedersen as a speaker at #cnaps2024, Prof. of Bioinformatics at @moma_dk. His current research focuses on the development of statistical methods for circulating tumor DNA (#ctDNA) detection and analysis of single-cell data.
4
7
526
Welcome @ClausLindbjerg, director of the “National Danish Research Centre for circulating tumor DNA guided treatment”, as a speaker at #cnaps2024. His research focuses on translation of basic molecular cancer knowledge into clinical tools.
4
9
412
GUIDE-MRD, a new initiative about: 👉Defining reference standards for ctDNA testing 👉Clinical validation of ctDNA-based MRD detection assays 👉Integrating ctDNA testing into clinical practice 👉therefore, improving patient outcomes @ClausLindbjerg is part of the consortium
1
2
8
318
These days at #ESCP2023 in Vilnius @TennaVesterman and @morntoft from the ctDNA Research Center present some exciting research @TennaVesterman about the possibilities of using ctDNA guided decisions - and @morntoft about the new RESPONSE project #ctDNA #CancerResearch @moma_dk
Wonderful talk by @TennaVesterman on ctDNA and colorectal cancer: a difficult topic made easy by a brilliant researcher. Surgeons be prepared! ctDNA is coming to your OR soon. #ESCP2023 @escp_tweets @moma_dk @cancer_dk
1
3
319
👩‍🎓PhD defence Thur September 21st at 10 AM Amanda Johansen @amanda_fbj will defend her thesis "Blood-based detection of disease in patients with colorectal cancer" at @HealthAarhusUni. Read more here: linkedin.com/posts/moma-auh_… #ctDNA #colorectalcancer 📸 AU Photo/Lars Kruse
1
13
377
Open Postdoc position at the Medical University of Graz, Austria! 👉There is an open Postdoc position within GUIDE.MRD – an EU project to benchmark and validate available ctDNA assays for MRD detection. #ctDNA #Postdoc
1
243
Til Danske Kræftforskningsdage 2023 fortæller @Amanda_fbj om sin forskning i cirkulerende tumor DNA Tillykke med at være en af de syv, der modtager prisen ”Exceptional Young Scientist Abstract”! 🎉 #DKD2023 #ctDNA #CancerResearch @moma_dk
Kan vi forudsige tilbagefald af kræft med en blodprøve? Det dykker @amanda_fbj ned i til #DKD2023, når hun i sessionen ’Aktuel Dansk Kræftforskning i Rampelyset’ går på scenen. Her vil hun få prisen "Exceptional Young Scientist Abstract". Tillykke! #SamarbejdeOmKræft #dkforsk
1
3
303